AcuityMD, the AI platform for MedTech, today announced $80 million in new funding to elevate its platform with advanced artificial intelligence (AI) capabilities and drive the company's mission of ...

AcuityMD has raised $80 million to add artificial intelligence features to its platform for medical device commercial teams.

Nucleus plans to expand capabilities at Rochester facility and finish construction of new site near Philadelphia.

Development teams that benefit most from high-resolution additive manufacturing are using it to ask better questions earlier ...

AcuityMD has raised $80 million—with a company valuation now nearing $1 billion—to use its artificial intelligence (AI) ...

AcuityMD plans to use AI to further advance its foundational platform designed for streamlining commercial execution ...

AcuityMD announced today that it secured $80 million in a Series C funding round to support its AI-powered platform.

The FDA said it intends to hire “substantial numbers” of medical device review staff as part of the agreement for the next ...

MEDDDICAL has launched a real-world evidence analytics and advisory service, offering structured guidance to pharmaceutical ...

White Brook Capital Partners, an investment management firm, released its first-quarter 2026 investor letter. A copy of the ...

Johnson & Johnson MedTech reported 4.6% growth in Q1, driven by a strong pipeline of cardiovascular and surgical innovations.